Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hyperpolarized MR Imaging with Carbon-13 Pyruvate in the Human Body

NCT06645691 is registered in ClinicalTrials.gov with National Heart Centre Singapore as lead sponsor.

NCT NCT06645691
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06645691 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hyperpolarized MR Imaging with Carbon-13 Pyruvate in the Human Body
Lead sponsor
National Heart Centre Singapore
Phase
Phase 2
Overall status
Recruiting
Start date
October 17, 2024
Completion date
May 31, 2028
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer diagnosis, cardiometabolic syndrome, cardiovascular diseases, healthy volunteers, heart failure